Volatile Market Flatlines Biotech IPOs

By: via Benzinga
The weak IPO market in the second half of 2015 continued into the early months of 2016, as several issues ran afoul of a volatile market ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.